Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 06, 2017 12:00 ET | Source: NEOVACS

NEOVACS : Agenda financier 2017

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} COMMUNIQUE DE PRESSE · COMMUNIQUE DE...
February 06, 2017 12:00 ET | Source: NEOVACS

NEOVACS: 2017 Financial Calendar

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PRESS RELEASE · PRESS RELEASE ·...
February 03, 2017 08:00 ET | Source: Neovacs

Neovacs Announces Independent Data and Safety Monitoring Board Supports Continuation of Phase IIb Clinical Trial for IFNα Kinoid in Lupus

PARIS, Feb. 03, 2017 (GLOBE NEWSWIRE) -- Neovacs (Alternext Paris:ALNEV), a leader in active immunotherapy for the treatment of autoimmune diseases, today announced that it received a positive data...
February 02, 2017 11:45 ET | Source: NEOVACS

Néovacs annonce que le Comité Indépendant de Surveillance des données et de la tolérance (IDSMB), confirme le bon déroulement de l'essai clinique de phase IIb dans le Lupus.

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PRESS RELEASE · PRESS RELEASE · PRESS...
January 25, 2017 08:00 ET | Source: Neovacs

Neovacs Reports First Positive Immunogenicity Results for IFNα Kinoid in Model of Type 1 Diabetes

PARIS and BOSTON, Jan. 25, 2017 (GLOBE NEWSWIRE) -- Neovacs (Alternext Paris: ALNEV), a leader in active immunotherapies for the treatment of autoimmune diseases, today announced the recommendation...
January 25, 2017 01:30 ET | Source: NEOVACS

NEOVACS : REPORTS FIRST POSITIVE IMMUNOGENICITY RESULTS FOR IFN-alpha KINOID IN MODEL OF TYPE 1 DIABETES

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PRESS RELEASE · PRESS RELEASE ·...
January 25, 2017 01:30 ET | Source: NEOVACS

NEOVACS : PRESENTE LES PREMIERS RESULTATS POSITIFS D'IMMUNOGENICITE POUR L'IFN-alpha KINOÏDE DANS LE DIABÈTE DE TYPE 1

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} COMMUNIQUE DE PRESSE · COMMUNIQUE DE...
January 06, 2017 08:00 ET | Source: Neovacs

Neovacs to participate in two upcoming investor events in the United States and France

PARIS and BOSTON, Jan. 06, 2017 (GLOBE NEWSWIRE) -- NEOVACS (Alternext Paris:ALNEV), leader in active immunotherapy for the treatment of autoimmune diseases, today announced that Neovacs will...
January 06, 2017 02:00 ET | Source: NEOVACS

Néovacs sera présente à deux conférences investisseurs

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} COMMUNIQUE DE PRESSE · COMMUNIQUE DE...
January 06, 2017 02:00 ET | Source: NEOVACS

Neovacs to participate in two upcoming investor events in the United States and France

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PRESS RELEASE· PRESS RELEASE· PRESS...